Epidemiology of Thyroid Cancer in Jordan Over Two Decades: 2000–2019
JCO Global Oncology · 2026-04 · 12 (4)
DOI: 10.1200/go-25-00415 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Global Oncology, 2026-04. Verfasst von Noor Almaani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, University of Jordan, Amman, Jordan. Hauptthemen laut MEDLINE: Thyroid Neoplasms. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
PURPOSE Thyroid cancer (TC) represents a growing global health burden with a significant increase in worldwide incidence. However, there are no comprehensive reports on TC incidence and its trend in Jordan to complement worldwide reports. This study investigates the incidence of TC in Jordan for the period 2000-2019. METHODS Data were extracted from the Jordan Cancer Registry. Age- and sex-specific incidence rates, as well as overall age-standardized incidence rates (ASIRs), were computed and analyzed. ASIRs were computed using direct age standardization to the WHO world standard population. RESULTS In the period between 2000 and 2019, 3,857 new cases of TC were reported in Jordan; 23.9% occurred in males and 76.1% in females, with a male-to-female ratio of 1:3. Papillary TC constituted 79.2% of cases followed by follicular (9.2%) and medullary (2%) cancers. ASIR rose from 1.7 per 100,000 in 2000 to 5.6 per 100,000 in 2019 ( P < .001) with an average ASIR of 4.1 (1.4 in males and 6.3 in females). The annual increase in ASIR was statistically significant in most years. The highest ASIR was in women aged 30-39 years. Mean incidence age was approximately 42.9 years (range, 2-90). Almost half of the patients were aged 30-49 years. CONCLUSION This study represents the most comprehensive and updated epidemiologic analysis of TC in Jordan, highlighting a significant rise in incidence between 2000 and 2019, particularly among women aged 30-39 years. By providing long-term national data, this study contributes to a wider framework aimed at improving cancer surveillance, contextualizing global TC trends, and guiding future research in Jordan, where national cancer control strategies remain an evolving priority.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, School of Medicine, University of Jordan, Amman, Jordan.
- School of Nursing, University of Jordan, Amman, Jordan.
- Jordan Cancer Registry, Amman, Jordan.
- Department of Special Surgery, University of Jordan, Amman, Jordan.
- Division of Endocrinology, Department of Internal Medicine, University of Jordan, Amman, Jordan.
- School of Medicine, University of Jordan, Amman, Jordan.
ORCID-Profile: Noor Almaani, Hamza Alduraidi, Nader Albsoul, Ayman Mismar, Nidal A Younes, Farah Bani Khalid, Malik E Juweid
Zitieren
APA
Almaani, N., Alduraidi, H., Nimri, O., Albsoul, N., Mismar, A., Alhawari, H., Al-Momani, M., Younes, N. A., Bdeir, A., Bani Khalid, F., Maani, T., Al-Abbadi, M. A., & Juweid, M. E. (2026). Epidemiology of Thyroid Cancer in Jordan Over Two Decades: 2000–2019. JCO Global Oncology, 12(4). https://doi.org/10.1200/go-25-00415
Vancouver
Almaani N, Alduraidi H, Nimri O, Albsoul N, Mismar A, Alhawari H, et al. Epidemiology of Thyroid Cancer in Jordan Over Two Decades: 2000–2019. JCO Global Oncology. 2026;12(4). doi:10.1200/go-25-00415
BibTeX
@article{Almaani2026,
author = {Almaani, Noor and Alduraidi, Hamza and Nimri, Omar and Albsoul, Nader and Mismar, Ayman and Alhawari, Hussam and Al-Momani, Munther and Younes, Nidal A and Bdeir, Adan and Bani Khalid, Farah and Maani, Tarek and Al-Abbadi, Mousa A and Juweid, Malik E},
title = {Epidemiology of Thyroid Cancer in Jordan Over Two Decades: 2000–2019},
journal = {JCO Global Oncology},
year = {2026},
volume = {12},
number = {4},
doi = {10.1200/go-25-00415}
}
EUVIMED